AI will benefit in that it
(i) produces more accurate results,
(ii) provide quicker turn-around time,
(iii) cut down human labour costs (but some level of human expertise is still required)
Where I think AI will make a difference is with the distributorship agreement with EnvoyAI and any partners.
It gives RHT a competitive advantage.
Q4 19 marks the about 9 mths since FDA approval and the EnvoyAI agreement. We should see some benefits trickling through but I think Q4 19 and Q1 2020 results will be the most exciting. As the clinical trials are approved and FerriSmart is used we should see a vast change on revenue.
What i like are these statements:
"the addition of a further 60 hospitals and imaging centresusing Resonance Health services either commercially or inclinical trials; and"
"Clinical trial work won this financial year resulted in a combined total dollar value of approximately US$1,530,200 (see ASXannouncements dated 23 August 2018, 29 October 2018, and 31 October 2018)."
- Forums
- ASX - By Stock
- RHT
- Ann: Annual Report to shareholders
Ann: Annual Report to shareholders, page-7
Featured News
Add RHT (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.0¢ |
Change
0.002(3.45%) |
Mkt cap ! $26.81M |
Open | High | Low | Value | Volume |
6.0¢ | 6.0¢ | 5.8¢ | $7.268K | 124.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 151999 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 100541 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 151999 | 0.056 |
1 | 100000 | 0.053 |
2 | 241999 | 0.050 |
1 | 10427 | 0.048 |
1 | 22221 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 100541 | 2 |
0.064 | 15765 | 1 |
0.065 | 55000 | 2 |
0.066 | 25000 | 1 |
0.067 | 29344 | 1 |
Last trade - 11.29am 04/10/2024 (20 minute delay) ? |
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
RHT (ASX) Chart |